Theme

Clinical Trials and Therapeutics

‘Providing strong support for clinical trials infrastructure’

Clinical trials infographic

‘IDeAC members from this theme are currently involved in over 30 clinical trials in dementia and neurological conditions’

There is a long history of dementia, brain ageing and neurodegenerative disease trials in Southampton. The Memory Assessment and Research Centre (Moorgreen Hospital, Southern Health FT) has a strong track record of delivery in dementia trials and participated in the earliest trials of cognitive enhancing medication for dementia. At Southampton, the Neurosciences Research Group conducts Phase 2 and Phase 3 trials through the University Hospital Southampton NIHR CRF facility for a range of dementias.

The nature of clinical trials fosters external collaboration, and regional, national and international links are already established. The Clinical Research Network provides strong support for clinical trials infrastructure in the region, and a regional network of memory clinics supports recruitment to trials.

Theme leads

IDeAC members from this theme are currently involved in over 30 clinical trials in dementia and neurological conditions active at Southampton sites, including international trials of cutting edge investigational therapeutic compounds.

Dr Boyd Ghosh

Clinical Trials

Dr Christopher Kipps

Clinical Research lead

Dr Jay Amin

Clinical Trials

Dr Roxana Carare

Vascular

Research

The theme bridges other themes with strong links to the Clinical Diagnosis and Prognosis theme, the Community and Post-Diagnostic Care theme and the NIHR Applied Research Collaboration (NIHR ARC).

pile of printing papers

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of dementia. However, people with DLB often experience...

More info
human brain figurine

Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are two neurodegenerative cause of dementia, in which patients are...

More info
clear glass bottle

Phase 1 trial of bepranemab in progressive supranuclear palsy

More info
clear glass bottle

Phase 1 first in human clinical trial in patients with progressive supranuclear palsy.

More info
clear glass bottle

Phase 2/3 clinical trial investigating the use of Atomoxetine to treat impulsivity

More info

The gastrointestinal tract in humans is one of the largest interfaces between the host and the environment. Different bacteria in...

More info

Inflammation is the body’s normal response to injury and infection. It can be healthy or harmful depending on the situation....

More info